Advances in Cancer Research

Edited by

  • George Vande Woude, Director, Van Andel Research Institute, Grand Rapids, MI, USA
  • George Klein, Karolinska Insitutet, Stockholm, Sweden

The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents outstanding and original reviews on a variety of topics including NY-ESO-1: review of an immunogenic tumor antigen; Order, disorder, death: lessons from a superorganism; Control of differentiation in progression of epithelial tumors; Cancer vaccines: preclinical studies and novel strategies; Clinical results of vaccine therapy for cancer: learning from history for improving the future; Immunodominance and immunodomination: critical factors in developing effective CD8+ T-cell based cancer vaccines; NK cell receptors as tools in cancer immunotherapy; Innate immune recognition and suppression of tumors; Inhibitors of the HSP90 molecular chaperone: current status.
View full description


Researchers and students in the basic and clinical science of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology and molecular biology.


Book information

  • Published: July 2006
  • ISBN: 978-0-12-006695-7

Table of Contents

NY-ESO-1: Review of an Immunogenic Tumor Antigen.Order, Disorder, Death: Lessons from a Superorganism.Control of Differentiation in Progression of Epithelial Tumors.Cancer Vaccines: Preclinical Studies and Novel Strategies.Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future.Immunodominance and Immunodomination: Critical Factors in Developing Effective CD8+ T-Cell Based Cancer Vaccines.NK Cell Receptors as Tools in Cancer Immunotherapy.Innate Immune Recognition and Suppression of Tumors.Inhibitors of the HSP90 Molecular Chaperone: Current Status.